Anticholinergics may play more roles in chronic obstructive pulmonary disease  

作　　者：SHEN Ning HE Bei 

机构地区：[1]Department of Respiratory Diseases, Peking University Third Hospital, Beijing 100191, China

出　　处：《Chinese Medical Journal》2011年第1期8-10,共3页中华医学杂志（英文版）

摘　　要：Anticholinergic drugs are classified as bronchodilators and are commonly prescribed as such in clinical management of chronic obstructive pulmonary disease （COPD）, as the cholinergic tone appears to be the only reversible component of COPD. The famous UPLIFT （the Understanding Potential Long-term Impacts on Function with Tiotropium） trial showed that in patients with COPD, therapy with tiotropium was associated with improvements in lung function,Anticholinergic drugs are classified as bronchodilators and are commonly prescribed as such in clinical management of chronic obstructive pulmonary disease （COPD）, as the cholinergic tone appears to be the only reversible component of COPD. The famous UPLIFT （the Understanding Potential Long-term Impacts on Function with Tiotropium） trial showed that in patients with COPD, therapy with tiotropium was associated with improvements in lung function,

分 类 号：Q51[生物学—生物化学] TQ463.3[化学工程—制药化工]